ERK1/2 inhibitors (Green Valley Pharmaceutical/Chinese Academy of Sciences)

N/A

Report date: 2025/03/18 18:17:39
NME

Base Information

Drug NameERK1/2 inhibitors (Green Valley Pharmaceutical/Chinese Academy of Sciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionExtracellular-signal-regulated kinase 2 inhibitorsExtracellular-signal-regulated kinase1 inhibitors
TargetsExtracellular-signal-regulated kinase1Extracellular-signal-regulated kinase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Greenvalley Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChinese Academy Of SciencesShanghai Greenvalley Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A